Half-year report · Q2
4480.TEDINET S100WJ2N
Period2025-01-01 → 2025-06-30
Filed2025-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥29.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | ¥1.5bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥2.3bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.8bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥647m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥647m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥47.4bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥45.2bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥42.2bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥29.4bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥25.0bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.1bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.5bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥19.0bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.5bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥19.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.9bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.5bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6.3bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.7bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥8.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥11.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥11.1bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥20.05 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.17 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.9 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥19.95 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.62 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.5 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 38.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.1% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥2.9bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥4.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥4.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥51m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥589m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥589m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥349m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥4.4bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥2.2bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥43m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥239m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥239m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥132m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥2m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥4.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 534
| Item | Context | Value | Unit |
|---|---|---|---|
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -13000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 5500000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -5471000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 15351000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 18993000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 20852000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 13521000000 | JPY |
| Salaries and allowances sga | Prior1YTDDuration | 2831000000 | JPY |
| Salaries and allowances sga | CurrentYTDDuration | 3944000000 | JPY |
| Depreciation sga | Prior1YTDDuration | 222000000 | JPY |
| Depreciation sga | CurrentYTDDuration | 413000000 | JPY |
| Business consignment expenses sga | Prior1YTDDuration | 688000000 | JPY |
| Business consignment expenses sga | CurrentYTDDuration | 875000000 | JPY |
| Advertising expenses sga | Prior1YTDDuration | 468000000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 628000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | 8000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | 2000000 | JPY |
| Provision for others sga | Prior1YTDDuration | 77000000 | JPY |
| Provision for others sga | CurrentYTDDuration | -98000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 10864000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | 3602000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | 239000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 14706000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 14706000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -2000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 10866000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | 3602000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | 239000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 14708000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -2000000 | JPY |
| Net sales | Prior1YTDDuration | 14706000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 4596000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | 43000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | -132000000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 4507000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -2246000000 | JPY |
| Operating income | Prior1YTDDuration | 2261000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 13407000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E33586-000MedicalPlatformBusinessReportableSegmentMember | 4468000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E33586-000NewBusinessDevelopmentServicesReportableSegmentMember | 589000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 18465000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 18465000000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E33586-000RecruitmentPlatformBusinessReportableSegmentMember | 1000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |